Clinical Trial Details
EORTC-1202-STBSG
Back to Clinical Trials Database
Phase II trial of cabazitaxel in metastatic or inoperable locally advanced dedifferentiated liposarcoma.
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 07-Aug-2014 Date Step1 close: 22-Mar-2019 Date Step2 close: 22-Mar-2019 |
Data management at EORTC | Yes |
Design |
Phase 2 Not randomized / N.A. |
Targeted Sample size | EORTC Groups: 50 - All Groups: 50 |
Treatment |
Drug Cabazitaxel |
Study Staff |
Richard L. Hayward (Study Coordinator) , NHS Lothian - Western General Hospital, Edinburgh Saskia Litiere (Statistician) , EORTC Headquarters, Brussels Hafida Lmalem (Data Manager) , EORTC Headquarters, Brussels Jammbe Musoro (Statistician) , EORTC Headquarters, Brussels Sandrine Rivrain (Pharmacovigilance Manager) , EORTC Headquarters, Brussels Ionela Stanciu (Clinical Operations Manager) , EORTC Headquarters, Brussels Leen Wijnen (Data Manager) , EORTC Headquarters, Brussels Xiao Mang Zhou (Junior RAM) , EORTC Headquarters, Brussels |
Type of cancer | Soft Tissue and Bone Sarcoma |
Participating groups | EORTC Soft Tissue and Bone Sarcoma Group |
Recruiting centers |
Centre Georges-Francois-Leclerc (DIJON CEDEX, France) Centre Leon Berard (Lyon, France) Clatterbridge Cancer Center - Wirral (Wirral, United Kingdom) Hopital de La Timone (APHM) (MARSEILLE CEDEX 5, France) IRCCS - Fondazione Istituto Nazionale dei Tumori (Milano, Italy) IRCCS - Istituto Oncologico Veneto (Padova, Italy) Institut Jules Bordet (Anderlecht, Belgium) Leiden University Medical Centre (Leiden, Netherlands) NHS Lothian - Western General Hospital (Edinburgh, United Kingdom) Radboud University Medical Center Nijmegen (Nijmegen, Netherlands) Royal Marsden Hospital - Chelsea, London (London, United Kingdom) The Christie NHS Foundation Trust (Manchester, United Kingdom) The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, Netherlands) Universitair Ziekenhuis Antwerpen (Edegem, Belgium) |
Protocol summary | http://clinicaltrials.gov/study/NCT01913652 |
NCT number | NCT01913652 |
EudraCT | 2012-003672-39 |
Financial Support |
Educational Grant EORTC Group |